Greetings, ladies and gentlemen. Welcome to the Home Bancshares, Inc. Second Quarter 2025 Earnings Call. The purpose of this call is to discuss the information and data provided in the quarterly earnings release issued after the market closed yesterday. The company presenters will begin with prepared remarks, then entertain questions.

Recent portfolio additions are yielding slightly below the 7.6% core yield reported for Q2 2025, as noted by Jason Estes. Expense Outlook: Projected Q3 total expenses of $10 million, split between $1 million in oil and gas and $9 million in other expenses,

Summit Therapeutics surged by 16.05 percent on Wednesday to close at $28.27 apiece, leading the rally of the overall biotechnology sector, as investors repositioned portfolios ahead of the release of

Westamerica Bancorp (WABC) on Thursday reported net income of $29.1 million in its second quarter. The San Rafael, California-based bank said it

Netflix exceeded Wall Street earnings expectations for the second quarter, driven by the final season of global phenomenon “Squid Game,” but shares dropped 1.8% to $1,897 in after-hours trading as investors expressed disappointment with the company’s conservative revenue guidance for 2025.

Bank OZK (OZK) stock gained 1.1% in Thursday after-hours trading after the bank posted record earnings that exceeded the Wall Street consensus.

Stocks jumped to record highs on Thursday, with investors brushing off the latest Trump-Powell drama to focus on strong earnings and robust economic data.